Search details
1.
Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study.
J Hepatol
; 78(1): 133-141, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36341767
2.
Comparison of safety outcomes of anticancer drugs in Japanese and non-Japanese patients in multi-regional clinical trials: meta-analysis of safety profiles.
Invest New Drugs
; 41(3): 483-492, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-37162707
3.
Impact of bodyweight-based starting doses on the safety and efficacy of lenvatinib in primarily Japanese patients with hepatocellular carcinoma.
Hepatol Res
; 52(9): 784-793, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35670187
4.
Comparison of efficacy outcomes of anticancer drugs between Japanese patients and the overall population.
Int J Clin Oncol
; 26(2): 296-304, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33057897
5.
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.
Lancet
; 391(10126): 1163-1173, 2018 03 24.
Article
in English
| MEDLINE | ID: mdl-29433850
6.
Crystallite Size Increase of Silver Nanoparticles by Ligand Exchange and Subsequent Washing Process with Antisolvent.
J Nanosci Nanotechnol
; 19(8): 4565-4570, 2019 Aug 01.
Article
in English
| MEDLINE | ID: mdl-30913749
7.
Polydopamine-Coated Solid Silica Nanoparticles Encapsulating IR-783 Dyes: Synthesis and NIR Fluorescent Cell Imaging.
ACS Omega
; 9(18): 19932-19939, 2024 May 07.
Article
in English
| MEDLINE | ID: mdl-38737067
8.
Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trial.
Lung Cancer
; 191: 107557, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38626709
9.
Room-temperature coalescence of Pd nanoparticles with sacrificial templates and sintering agents, and their catalytic activities in the Suzuki coupling reaction.
RSC Adv
; 12(23): 14535-14543, 2022 May 12.
Article
in English
| MEDLINE | ID: mdl-35702252
10.
Helically aligned fused carbon hollow nanospheres with chiral discrimination ability.
Nanoscale
; 14(10): 3748-3757, 2022 Mar 10.
Article
in English
| MEDLINE | ID: mdl-35167641
11.
Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies.
Expert Rev Anticancer Ther
; 22(4): 383-400, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35260027
12.
Baseline Liver Function and Subsequent Outcomes in the Phase 3 REFLECT Study of Patients with Unresectable Hepatocellular Carcinoma.
Liver Cancer
; 10(5): 510-521, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34721512
13.
Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial.
Lancet Gastroenterol Hepatol
; 6(8): 649-658, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34087115
14.
Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT.
J Gastroenterol
; 56(6): 570-580, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33948712
15.
Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study.
Clin Cancer Res
; 27(17): 4848-4858, 2021 09 01.
Article
in English
| MEDLINE | ID: mdl-34108184
16.
Crystal structure of 7,7'-[(pyridin-2-yl)methyl-ene]bis-(5-chloro-quinolin-8-ol).
Acta Crystallogr E Crystallogr Commun
; 76(Pt 8): 1271-1274, 2020 Aug 01.
Article
in English
| MEDLINE | ID: mdl-32844012
17.
REFLECT-a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset.
J Gastroenterol
; 55(1): 113-122, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31720835
18.
Crystal structure of catena-poly[[[bis-(3-oxo-1,3-di-phenyl-prop-1-enolato-κ2 O,O')zinc(II)]-µ2-tris-[4-(pyridin-3-yl)phen-yl]amine-κ2 N:N'] tetra-hydro-furan monosolvate].
Acta Crystallogr E Crystallogr Commun
; 75(Pt 10): 1432-1435, 2019 Oct 01.
Article
in English
| MEDLINE | ID: mdl-31636971
19.
Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses.
J Clin Pharmacol
; 57(9): 1138-1147, 2017 09.
Article
in English
| MEDLINE | ID: mdl-28561918
20.
Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma.
J Gastroenterol
; 52(4): 512-519, 2017 Apr.
Article
in English
| MEDLINE | ID: mdl-27704266